Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 12:55 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2689–2712 of 18,280 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Controlled Group Clear all

Conditions: Pediatric Obesity
Interventions: NOURISH, Wellness Group; Behavioral · Other
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 184 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Knee Osteoarthritis
Interventions: Stem Cell Support Formula, Placebo; Dietary Supplement
Lead sponsor: Regenexx, LLC; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Broomfield, Colorado • Lone Tree, Colorado

Conditions: Health Promotion, Prevention, Risk Reduction Behavior
Interventions: Outreach mailer, Humor/Salience, Doctor's authority, Information; Behavioral
Lead sponsor: Geisinger Clinic; Other
Eligibility: 18 Years and older
Enrollment: 21,562 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Danville, Pennsylvania

Conditions: Healthy
Interventions: Ad26.ZEBOV 5*10^10 viral particles (vp), Ad26.ZEBOV 2*10^10 (vp), Ad26.ZEBOV 0.8*10^10 (vp), MVA-BN-Filo 1*10^8 Infectious Unit [Inf. U.], MVA-BN-Filo 5*10^7 Inf. U., Placebo; Biological
Lead sponsor: Janssen Vaccines & Prevention B.V.; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 525 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 6
States / cities: Huntsville, Alabama • San Diego, California • Melbourne, Florida + 3 more

Conditions: Training Group
Interventions: training; Behavioral
Lead sponsor: Kansas State University; Other
Eligibility: 18 Years and older
Enrollment: 87 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Manhattan, Kansas

Conditions: Opioid Use Disorder, Sleep, Circadian Rhythms, fMRI Research
Interventions: AYO light glasses (experimental), AYO light glasses (comparator); Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 60 Years
Enrollment: 105 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Obesity
Interventions: APD356; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Thyroidectomy, Parathyroidectomy, Opioid Use, Pain, Postoperative
Interventions: Quality improvement bundle; Other
Lead sponsor: The Methodist Hospital Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Parkinson's Disease
Interventions: rasagiline mesylate, 1.0 mg rasagiline mesylate, Placebo; Drug · Other
Lead sponsor: Teva Branded Pharmaceutical Products R&D, Inc.; Industry
Eligibility: 30 Years and older
Enrollment: 472 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2003
U.S. locations: 4
States / cities: Chicago, Illinois • New York, New York • Rochester, New York + 1 more

Conditions: Breast Cancer
Interventions: Mobile phone app + patient navigation; Behavioral
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years and older · Female only
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Ankle Injury, Foot Injury, Lower Extremity Injury
Interventions: Mental Health App; Device
Lead sponsor: University of California, San Diego; Other
Eligibility: 13 Years to 18 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: San Diego, California

Conditions: Diabetes Mellitus, Type 2
Interventions: Vildagliptin, metformin; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 78 Years
Enrollment: 914 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2006
U.S. locations: 1
States / cities: East Hanover, New Jersey

Conditions: Overweight, Obese
Interventions: Exercise Energy Expenditure 300 kcal/day, Exercise Energy Expenditure 600 kcal/day; Other
Lead sponsor: USDA Grand Forks Human Nutrition Research Center; Federal
Eligibility: 18 Years to 40 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Grand Forks, North Dakota

Conditions: Scar, Skin Scarring, Skin Cancer, Wound Heal, Wound of Skin, Surgical Wound, Patient Satisfaction, Patient Preference, Surgical Incision
Interventions: Hydrocolloid dressing, Petrolatum jelly dressing; Device · Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 146 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Carmel, Indiana

Conditions: Postpartum Depression
Interventions: WB001, ED001; Device
Lead sponsor: Woebot Health; Industry
Eligibility: 22 Years to 45 Years · Female only
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 8
States / cities: Lafayette, California • Santa Ana, California • DeLand, Florida + 5 more

Conditions: Exercise Therapy
Interventions: Metronome; Device
Lead sponsor: Aultman Health Foundation; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Canton, Ohio

Conditions: Healthy Children, CP (Cerebral Palsy), CP, Cerebral Palsy
Interventions: Brain-Computer Interface (BCI)-HABIT-VR, Hand and Bimanual Intensive Therapy Virtual Reality (HABIT-VR); Device
Lead sponsor: University of Nebraska; Other
Eligibility: 6 Years to 17 Years
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Hidradenitis Suppurativa
Interventions: Verbal consultation, Written Action Plan; Behavioral
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years to 89 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Program Evaluation, Child Sexual Abuse, Perpetration of Child Sexual Abuse, Prevention Intervention
Interventions: Help Wanted Prevention Intervention, Waitlist Control; Other
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years and older · Male only
Enrollment: 147 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pemphigus
Interventions: Infliximab, Placebo Comparator; Drug · Other
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 4
States / cities: Los Angeles, California • Iowa City, Iowa • Durham, North Carolina + 1 more

Conditions: Long COVID, Postural Orthostatic Tachycardia Syndrome, Dysautonomia, Myalgic Encephalomyelitis, Chronic Fatigue Syndrome, Long Covid19
Interventions: Wearable device; Device
Lead sponsor: Scripps Translational Science Institute; Other
Eligibility: 18 Years and older
Enrollment: 100,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Post-Traumatic Stress Disorder
Interventions: Topiramate; Drug
Lead sponsor: Creighton University; Other
Eligibility: 19 Years to 64 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2004
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Chagas Disease
Interventions: LXE408, Placebo, Benznidazole; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 4
States / cities: Sylmar, California • Gainesville, Florida • Boston, Massachusetts + 1 more

Conditions: Stroke
Interventions: Gamification with social incentives; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Search by objective public record fields.

NOURISH: Nourishing Our Understanding of Role Modeling to Improve Support and Health

Randomized Trial of Regenexx Stem Cell Support Formula

Encouraging Overdue Healthcare Appointment Scheduling Among Patients With Chronic Diseases

A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA-BN-Filo in Healthy Adult Participants

Impacts of Training on Effortful Listening

The Effect of Light Intervention on Recovery in Individuals With Opioid Use Disorder (OUD)

Safety and Efficacy of APD356 in the Treatment of Obesity

Opioid Use After Thyroid and Parathyroid Surgeries

Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations

Improving Adherence to EHT Among Breast Cancer Patients

Dance Mental Health App

Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin Alone

Exercise and Weight Control

Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment

[Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to TAU in Postpartum Depression]

Effects of a Metronome on Functional Outcomes in Aquatic Therapy

Training Upper Limbs of Neurodiverse Children by Connecting Brain Activities to a Virtual Reality Based Game

Evaluating the Effect of a Written Action Plan on Comfort and Understanding of Hidradenitis Suppurativa

Help Wanted: Evaluating a Prevention Intervention for People With Sexual Interest in Children

Use of Infliximab for the Treatment of Pemphigus Vulgaris

The Long COVID-19 Wearable Device Study

Topiramate in the Treatment of Posttraumatic Stress Disorder in Civilians

A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.

Behavioral Economics and Mobility After Stroke (BE Mobile)